Balasubramanian Ravikumar, Choi Jin-Ho, Francescatto Ludmila, Willer Jason, Horton Edward R, Asimacopoulos Eleni P, Stankovic Konstantina M, Plummer Lacey, Buck Cassandra L, Quinton Richard, Nebesio Todd D, Mericq Veronica, Merino Paulina M, Meyer Brian F, Monies Dorota, Gusella James F, Al Tassan Nada, Katsanis Nicholas, Crowley William F
Harvard Reproductive Endocrine Sciences Center & Reproductive Endocrine Unit of the Department of Medicine, and Medicine.
Harvard Reproductive Endocrine Sciences Center & Reproductive Endocrine Unit of the Department of Medicine, and Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul 138-736, Korea;
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17953-8. doi: 10.1073/pnas.1417438111. Epub 2014 Dec 3.
Inactivating mutations in chromodomain helicase DNA binding protein 7 (CHD7) cause CHARGE syndrome, a severe multiorgan system disorder of which Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is a minor feature. Recent reports have described predominantly missense CHD7 alleles in IGD patients, but it is unclear if these alleles are relevant to causality or overall genetic burden of Kallmann syndrome (KS) and normosmic form of IGD. To address this question, we sequenced CHD7 in 783 well-phenotyped IGD patients lacking full CHARGE features; we identified nonsynonymous rare sequence variants in 5.2% of the IGD cohort (73% missense and 27% splice variants). Functional analyses in zebrafish using a surrogate otolith assay of a representative set of these CHD7 alleles showed that rare sequence variants observed in controls showed no altered function. In contrast, 75% of the IGD-associated alleles were deleterious and resulted in both KS and normosmic IGD. In two families, pathogenic mutations in CHD7 coexisted with mutations in other known IGD genes. Taken together, our data suggest that rare deleterious CHD7 alleles contribute to the mutational burden of patients with both KS and normosmic forms of IGD in the absence of full CHARGE syndrome. These findings (i) implicate a unique role or preferential sensitivity for CHD7 in the ontogeny of GnRH neurons, (ii) reiterate the emerging genetic complexity of this family of IGD disorders, and (iii) demonstrate how the coordinated use of well-phenotyped cohorts, families, and functional studies can inform genetic architecture and provide insights into the developmental biology of cellular systems.
染色质结构域解旋酶DNA结合蛋白7(CHD7)的失活突变会导致CHARGE综合征,这是一种严重的多器官系统疾病,其中孤立性促性腺激素释放激素(GnRH)缺乏症(IGD)是其一个次要特征。最近的报告描述了IGD患者中主要为错义CHD7等位基因,但尚不清楚这些等位基因是否与卡尔曼综合征(KS)和嗅觉正常型IGD的因果关系或整体遗传负担相关。为了解决这个问题,我们对783名缺乏完整CHARGE特征的表型良好的IGD患者进行了CHD7测序;我们在5.2%的IGD队列中鉴定出非同义罕见序列变异(73%为错义变异,27%为剪接变异)。使用这些CHD7等位基因的代表性集合进行的斑马鱼替代耳石试验功能分析表明,在对照组中观察到的罕见序列变异没有功能改变。相比之下,75%的与IGD相关的等位基因是有害的,会导致KS和嗅觉正常型IGD。在两个家族中,CHD7的致病突变与其他已知IGD基因的突变共存。综上所述,我们的数据表明,在没有完整CHARGE综合征的情况下,罕见的有害CHD7等位基因会导致KS和嗅觉正常型IGD患者的突变负担。这些发现(i)暗示CHD7在GnRH神经元的个体发生中具有独特作用或优先敏感性,(ii)重申了这一IGD疾病家族新出现的遗传复杂性,(iii)展示了如何协调使用表型良好的队列、家族和功能研究来了解遗传结构,并为细胞系统的发育生物学提供见解。